IART Split History

Integra LifeSciences Holdings (IART) has 3 splits in our IART split history database. The first split for IART took place on May 26, 1998. This was a 1 for 2 reverse split, meaning for each 2 shares of IART owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 500 share position following the split. IART's second split took place on July 01, 2015. This was a 1106 for 1000 split, meaning for each 1000 shares of IART owned pre-split, the shareholder now owned 1106 shares. For example, a 500 share position pre-split, became a 553 share position following the split. IART's third split took place on January 04, 2017. This was a 2 for 1 split, meaning for each share of IART owned pre-split, the shareholder now owned 2 shares. For example, a 553 share position pre-split, became a 1106 share position following the split.

When a company such as Integra LifeSciences Holdings splits its shares, the market capitalization before and after the split takes place remains stable, meaning the shareholder now owns more shares but each are valued at a lower price per share. Often, however, a lower priced stock on a per-share basis can attract a wider range of buyers. If that increased demand causes the share price to appreciate, then the total market capitalization rises post-split. This does not always happen, however, often depending on the underlying fundamentals of the business. When a company such as Integra LifeSciences Holdings conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.

Looking at the IART split history from start to finish, an original position size of 1000 shares would have turned into 1106 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Integra LifeSciences Holdings shares, starting with a $10,000 purchase of IART, presented on a split-history-adjusted basis factoring in the complete IART split history.

Growth of $10,000.00 Without Dividends Reinvested
Start date:	09/24/2013
End date:	09/21/2023
Start price/share:	$17.76
End price/share:	$38.72
Dividends collected/share:	$0.00
Total return:	118.02%
Average Annual Total Return:	8.11%
Starting investment:	$10,000.00
Ending investment:	$21,805.49
Years:	10.00

About Integra LifeSciences Holdings

Integra LifeSciences Holdings is engaged in medical technology. Co.'s global reportable business segments include: Codman Specialty Surgical and Tissue Technologies. The Codman Specialty Surgical segment focuses on the management of multiple disease states, including brain tumors, traumatic brain injury, hydrocephalus and other neurological conditions. The Tissue Technologies segment has a regenerative platform that primarily addresses the needs of plastic, reconstructive and general surgeons focused on the treatment of acute wounds, such as burns, chronic wounds, including diabetic foot ulcers, and surgical tissue repair, such as hernia, tendon, peripheral nerve repair and protection. According to our IART split history records, Integra LifeSciences Holdings has had 3 splits.